The bile acid derivative obeticholic acid (OCA) is a potent FXR agonist [10], recently approved in the US and Europe for the treatment of primary biliary cholangitis (PBC) [11][12]. The gene discussed is NR1H4; the disease is primary biliary cholangitis.